These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31165767)

  • 1. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
    Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
    Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
    Cui G; Yuan A; Li Z; Goll R; Florholmen J
    Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
    Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
    PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
    Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
    J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
    Cui G; Li Z; Ren J; Yuan A
    Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.
    Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X
    Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of ST2 on regulatory T cells is associated with cancer associated fibroblast-derived IL-33 in laryngeal cancer.
    Zhao Y; Sun J; Liang Y; Jiang X; Tang X; Sun Y; Xu C; Wan G; Sun J; Pan C
    Pathol Res Pract; 2022 Sep; 237():154023. PubMed ID: 35908385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
    Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
    Li Y; Shi J; Qi S; Zhang J; Peng D; Chen Z; Wang G; Wang Z; Wang L
    J Exp Clin Cancer Res; 2018 Aug; 37(1):196. PubMed ID: 30119635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis.
    Ngo Thi Phuong N; Palmieri V; Adamczyk A; Klopfleisch R; Langhorst J; Hansen W; Westendorf AM; Pastille E
    Front Immunol; 2021; 12():669787. PubMed ID: 34335571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
    Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
    Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33/ST2 Axis Protects Against Traumatic Brain Injury Through Enhancing the Function of Regulatory T Cells.
    Xie D; Miao W; Xu F; Yuan C; Li S; Wang C; Junagade A; Hu X
    Front Immunol; 2022; 13():860772. PubMed ID: 35432343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling.
    Son J; Cho JW; Park HJ; Moon J; Park S; Lee H; Lee J; Kim G; Park SM; Lira SA; Mckenzie AN; Kim HY; Choi CY; Lim YT; Park SY; Kim HR; Park SH; Shin EC; Lee I; Ha SJ
    Cancer Immunol Res; 2020 Nov; 8(11):1393-1406. PubMed ID: 32878747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.
    Landskron G; De la Fuente López M; Dubois-Camacho K; Díaz-Jiménez D; Orellana-Serradell O; Romero D; Sepúlveda SA; Salazar C; Parada-Venegas D; Quera R; Simian D; González MJ; López-Köstner F; Kronberg U; Abedrapo M; Gallegos I; Contreras HR; Peña C; Díaz-Araya G; Roa JC; Hermoso MA
    Front Immunol; 2019; 10():1394. PubMed ID: 31281317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.
    Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB
    Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
    Eissmann MF; Dijkstra C; Wouters MA; Baloyan D; Mouradov D; Nguyen PM; Davalos-Salas M; Putoczki TL; Sieber OM; Mariadason JM; Ernst M; Masson F
    Cancer Immunol Res; 2018 Apr; 6(4):409-421. PubMed ID: 29463593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST2 as checkpoint target for colorectal cancer immunotherapy.
    Van der Jeught K; Sun Y; Fang Y; Zhou Z; Jiang H; Yu T; Yang J; Kamocka MM; So KM; Li Y; Eyvani H; Sandusky GE; Frieden M; Braun H; Beyaert R; He X; Zhang X; Zhang C; Paczesny S; Lu X
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T
    Pascual-Reguant A; Bayat Sarmadi J; Baumann C; Noster R; Cirera-Salinas D; Curato C; Pelczar P; Huber S; Zielinski CE; Löhning M; Hauser AE; Esplugues E
    Mucosal Immunol; 2017 Nov; 10(6):1431-1442. PubMed ID: 28198366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.